Our study further suggests that aberrant expression of microRNAs targeting TMPRSS2 may assemble a post-transcriptional regulatory network leading to a reduced expression of TMPRSS2 in HNSCC. This evidence concerns the gene TMPRSS2 and head and neck squamous cell carcinoma.